Kahan Bd
Impact in
- Transplantation top 1%
- Renal Transplantation Outcomes and Treatments
-
- Immune Cell Function and Interaction
Papers in
-
- Renal Transplantation Outcomes and Treatments 51
- Surgery 32
- Transplantation: Methods and Outcomes 19
- Organ Transplantation Techniques and Outcomes 16
- Co-authors
- Van Buren Ct (27 shared papers)H. Yamagishi (2 shared papers)Silvana Savoldi (1 shared paper)Joachim Grevel (5 shared papers)Camilo G. Barcenas (1 shared paper)Sara Gibbons (2 shared papers)Mark V. Jarowenko (1 shared paper)Scott A. Smith (1 shared paper)
- Journals
- Transplantation Proceedings (4 papers)PubMed (82 papers)
- Partner nations
- United States
In The Last Decade
Kahan Bd
83 papers receiving 660 citations
Peers
Comparison fields: 5 of 78
- Transplantation 276
- Immunology 126
- Pharmacy 27
- Pediatrics, Perinatology and Child Health 104
- Hematology 49
Countries citing papers authored by Kahan Bd
This map shows the geographic impact of Kahan Bd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kahan Bd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kahan Bd more than expected).
Fields of papers citing papers by Kahan Bd
This network shows the impact of papers produced by Kahan Bd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kahan Bd. The network helps show where Kahan Bd may publish in the future.
Co-authors
The 25 scholars most cited alongside Kahan Bd, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 86 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Biological and chemical characterization of human histocompatibility antigens. | 1971 | 37 |
| 2 | Hepatobiliary complications of cyclosporine therapy following renal transplantation. | 1987 | 34 |
| 3 | The value of serial serum trough cyclosporine levels in human renal transplantation. | 1984 | 34 |
| 4 | Effects of cyclosporine, azathioprine and prednisone on Kimura's disease and focal segmental glomerulosclerosis in renal transplant patients. | 1996 | 33 |
| 5 | Influence of blood transfusions on immune responsiveness. | 1982 | 28 |
| 6 | Lipid abnormalities in renal transplant recipients treated with cyclosporine. | 1989 | 26 |
| 7 | Effect of splenectomy upon tumor growth: characterization of splenic tumor-enhancing cells in vivo. | 1980 | 23 |
| 8 | The case against conversion to azathioprine in cyclosporine-treated renal recipients. | 1985 | 23 |
| 9 | Potential therapeutic interventions to avoid or treat chronic allograft dysfunction. | 2001 | 23 |
| 10 | Analysis of pharmacokinetic profiles in 232 renal and 87 cardiac allograft recipients treated with cyclosporine. | 1986 | 21 |
| 11 | Rapamycin and cyclosporine synergistically prolong heart and kidney allograft survival. | 1991 | 20 |
| 12 | Evaluation of chronic renal disease in heart transplant recipients: importance of pretransplantation native kidney histologic evaluation. | 1994 | 20 |
| 13 | Induction of transplantation tolerance by a single intrathymic injection of 3M KCl-extracted donor histocompatibility antigens combined with two doses of anti-rat alpha/beta-T cell receptor monoclonal antibodies. | 1994 | 18 |
| 14 | Prolongation by rapamycin of heart, kidney, pancreas, and small bowel allograft survival in rats. | 1991 | 18 |
| 15 | Cyclosporine: the base for immunosuppressive therapy--present and future. | 1993 | 17 |
| 16 | Pharmacokinetics and pharmacodynamics of cyclosporine. | 1989 | 15 |
| 17 | Relationship of cyclosporine pharmacokinetic parameters to clinical events in human renal transplantation. | 1986 | 15 |
| 18 | Clinical outcome in 36 patients after at least one and up to 5 years of steroid withdrawal based upon specific mixed lymphocyte reaction hyporesponsiveness toward the living related donor. | 1989 | 13 |
| 19 | Concentration-controlled immunosuppressive regimens using cyclosporine with sirolimus or brequinar in human renal transplantation. | 1995 | 12 |
| 20 | Optimization of cyclosporine therapy. | 1993 | 12 |
About Kahan Bd
Kahan Bd is a scholar working on Transplantation, Surgery, Pediatrics, Perinatology and Child Health, Epidemiology and Pharmacy, having authored 86 papers that have together received 723 indexed citations. Recurring topics across this work include Renal Transplantation Outcomes and Treatments (51 papers), Pharmacological Effects and Toxicity Studies (20 papers), Transplantation: Methods and Outcomes (19 papers), Organ Transplantation Techniques and Outcomes (16 papers), Oral and gingival health research (10 papers), Metabolism and Genetic Disorders (8 papers), Cytomegalovirus and herpesvirus research (7 papers) and Neurological Complications and Syndromes (7 papers). The work is most often cited by research in Transplantation (276 citations), Immunology (126 citations), Pharmacy (27 citations), Pediatrics, Perinatology and Child Health (104 citations) and Hematology (49 citations). Kahan Bd has collaborated with scholars based in United States. Frequent co-authors include Van Buren Ct, H. Yamagishi, Silvana Savoldi, Joachim Grevel, Camilo G. Barcenas, Sara Gibbons, Mark V. Jarowenko, Scott A. Smith, Frazier Oh and T Hamashima. Their work appears in journals such as Transplantation Proceedings and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.